Product Information

OXCARBAZEPINE 300 MG TABLET is a generic product labeled by ANI Pharmaceuticals, Inc., priced at $0.1741 per EA under NDC 62559022105. Its NADAC has been published 49 times since Dec 17, 2025.

FDA first approved this application on Dec 11, 2007. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

OXCARBAZEPINE 300 MG TABLET

Oxcarbazepine
$0.1741per EA

Strength

300 mg/1

NDC

62559022105

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Effective Date

11/18/2026

Active Ingredients

OXCARBAZEPINE

Approval Type

Generic (ANDA)

FDA Application

ANDA078005

FDA Approved

12/11/2007

TE Code

AB

On Market Since

7/15/2025

Pharmacological Classes

Anti-epileptic Agent
Decreased Central Nervous System Disorganized Electrical Activity

Price Statistics

The NADAC for OXCARBAZEPINE 300 MG TABLET has been published 49 times since Dec 17, 2025, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.

Current price$0.1741 per EA
All-time high$0.1741 (Nov 18, 2026)
All-time low$0.1635 (Jul 22, 2026)
52-week high$0.1741
52-week low$0.1635
Median price$0.1676
Average price$0.1681
Largest weekly change+2.8% (Oct 21, 2026)
Weeks tracked49
Tracking sinceDec 17, 2025

Price History

1W

+1.6%

1M

+4.4%

3M

+6.3%

6M

+4.5%

1Y

N/A

3Y

N/A

5Y

N/A

All

+0.7%

Generic Alternatives

The matcher finds 9 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 3% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of OXCARBAZEPINE 300 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for OXCARBAZEPINE 300 MG TABLET, manufactured by ANI Pharmaceuticals, Inc., is $0.1741 per EA (NDC 62559022105), effective Nov 18, 2026.

How has the price of OXCARBAZEPINE 300 MG TABLET changed over time?

Over the history we have for it, the NADAC for OXCARBAZEPINE 300 MG TABLET has held within roughly two percent of its current level. It has been tracked across 49 weekly CMS publications since Dec 17, 2025.

What are the highest and lowest recorded NADAC prices for OXCARBAZEPINE 300 MG TABLET?

Since Dec 17, 2025, the NADAC for OXCARBAZEPINE 300 MG TABLET has ranged from a low of $0.1635 (Jul 22, 2026) to a high of $0.1741 (Nov 18, 2026), with a median of $0.1676 per EA.

Are there cheaper alternatives to OXCARBAZEPINE 300 MG TABLET?

Yes. 9 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, OXCARBAZEPINE 300 MG TABLET, is $0.1691 per EA — about 3% below OXCARBAZEPINE 300 MG TABLET.

Who manufactures OXCARBAZEPINE 300 MG TABLET?

OXCARBAZEPINE 300 MG TABLET (NDC 62559022105) is labeled by ANI Pharmaceuticals, Inc., and CMS classifies it as a generic product.